Digestive System Diseases

633 trials 301 recruiting

Filter these 633 trials by phase, country and sponsor.

Open in Search →

A Study to Learn How Different Manufactured Products of the Study Medicine Called Ritlecitinib are Taken up Into the Blood in Healthy Adults… Ended

2023-505603-23-00 ulcerative colitis, Crohn’s Disease, alopecia areata, r 3 2024-01-29
Efficacy of oral lidocaine in preventing gastrointestinal disturbance in patients after abdominal surgery Ended

2022-503113-31-01 longitudinal laparotomy 4 2023-12-19
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors Ended

2022-502348-11-00 Pancreatic Neoplasms 1 2023-12-15
A research study looking at how the compound NNC0194-0499 works with birth control pills in women not able to bear children. Ended

2023-503595-24-00 Healthy volunteers (Non-alcoholic steatohepatitis (NASH 1 2023-12-14
A study to learn if atrasentan is safe and works in people with IgA nephropathy who are taking an SGLT2i Ended

2023-503828-13-00 Nephrology 4 2023-12-12
FLUOPANC II: A performance study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for fluorescence-guide… Ended

2023-510481-27-00 Pancreatic tumor 4 2023-12-11
Efficacy and Safety of JNJ-77242113 in Participants with Moderately to Severely Active Ulcerative Colitis Ended

2023-504673-20-00 Ulcerative Colitis 4 2023-12-06
First-in-human interleukin-15-transpresenting Wilms’ tumor protein 1-targeting autologous dendritic cell vaccination in cancer patients Ended

2024-515296-35-00 Histologically or cytologically confirmed solid tumor o 7 2023-12-06
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants with Moderate to Severe Ulcerative Colitis Ended

2022-503005-38-00 Ulcerative Colitis 4 2023-12-04
A MULTICENTER OPEN LABEL 3 MONTH SAFETY STUDY WITH TRADIPITANT IN PATIENTS WITH IDIOPATHIC OR DIABETIC GASTROPARESIS Ended

2023-503802-35-00 Idiopathic or diabetic gastroparesis with moderate to s 5 2023-11-29
A study in people with moderately to severely active ulcerative colitis to see how well an investigational treatment called PB016 works and … Ended

2022-502778-18-00 ulcerative colitis 5 2023-11-17
A prospective, multicentre open-label clinical trial to evaluate the efficacy of the fixed-dose combination of Doxylamine and Pyridoxine 10/… Ended

2023-505144-19-00 Nausea and vomiting of pregnancy 6 2023-10-31
Randomised, placebo-controlled clinical trial on the efficacy of Roleca® juniper 100 mg for dyspeptic digestive complaints such as cramps in… Ended

2023-504750-35-01 Treatment of dyspeptic digestive complaints (cramps in 6 2023-10-24
A clinical trial to learn how an investigational drug (norucholic acid) is absorbed, distributed, broken down, and removed from the body whe… Ended

2023-505862-27-00 Nonalcoholic fatty liver disease (NAFLD) 3 2023-10-10
A Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The… Ended

2024-512767-30-00 Eosinophilic Esophagitis 4 2023-09-28
PET study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to healthy participants and patients with Crohn’s disease Ended

2023-505471-78-00 Crohn's Disease 3 2023-09-25
Oral fluorescent tracer administration to detect of early esophageal adenocarcinomas Ended

2023-503801-12-00 Barrett's esophagus 4 2023-09-15
A Study to Investigate Bowel Urgency in Adults with Moderately to Severely Active Ulcerative Colitis Treated with Mirikizumab Ended

2022-502393-16-00 Moderately to Severely Active Ulcerative Colitis 5 2023-09-06
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-Line Treatment for Met… Ended

2024-515407-19-00 Metastatic pancreatic ductal adenocarcinoma (mPDAC) 5 2023-08-16
A single-arm, open-label study to evaluate the efficacy and safety of ABBV-668 in subjectswith moderate to severe ulcerative colitis Ended

2022-501263-41-00 Ulcerative Colitis 4 2023-08-10
FMT in IT-refractory HCC - FAB-HCC Pilot Study Ended

2024-516835-29-00 Hepatocellular Carcinoma 4 2023-08-04
MK-7480 Single Ascending Dose Study in Healthy Participants Ended

2023-505138-88-00 Non-alcoholic steatohepatitis 1 2023-08-03
A study to characterize the pharmacokinetic profile of norucholic acid (NCA) in patients with primary sclerosing cholangitis (PSC) Ended

2023-507027-37-00 Primary Sclerosing Cholangitis (PSC) 3 2023-07-20
Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis Ended

2023-506046-24-00 Ulcerative Colitis (UC) 4 2023-07-03